All News

It is happening again.

When I was diagnosed with a rare cancer at the “stump” of my appendix, I was surprised, considering I had my appendix removed more than a decade ago.

Stephen Peck created a nonprofit that addressed the unique needs of men caring for someone with cancer.

Choosing to share your cancer story is a very personal choice.

From Suzanne Somers’ death from metastatic breast cancer and Julia Louis-Dreyfus discusses her outlook on life post-diagnosis, here is what’s happening in the oncology space this week.

In this on-demand webinar series, CURE partnered with Look Good Feel Better to offer fun wig options for patients to wear after hair loss from cancer treatment.

In this on-demand webinar series, CURE partnered with Look Good Feel Better to discuss how patients with cancer can care for their wig.

In this on-demand webinar series, CURE partnered with Look Good Feel Better to show how patients who experienced hair loss from cancer treatment can style their wigs.

In this on-demand webinar series, CURE partnered with Look Good Feel Better to demonstrate how to put on and adjust a wig for comfort and appearance for patients with cancer who have experienced hair loss from treatment.

In this on-demand webinar series, CURE partnered with Look Good Feel Better to offer patients with cancer offered tips for haircare and hair loss before, during and after treatment.

Two phase 3 randomized trials focused on evaluating the safety and efficiency of anamorelin to treat adult patients with advanced non-small cell lung cancer linked with weight loss and cachexia.

Patients insured by Medicaid may be more likely to be affected by the ongoing cancer drug shortage, according to a recent survey.

Dear every oncology team...

Charlene Wexler, the Chicago-based author of the Laughter and Tears series of novels, is an ovarian cancer survivor who now has skin cancer. She told CURE® about how her son’s death from leukemia led to her re-invention as a writer.

I was diagnosed with a rare cancer in 2007, and it shaped who I am today.

Recent research has put a spotlight on a number of factors which could be used to estimate which patients with nonmetastatic, unfavorable-risk prostate cancer are at high risk for a shorter time until PSA recurrence and failure.

A first patient received samuraciclib plus Orserdu in a phase 2 trial, a treatment combination for some patients with HR-positive, HER2-negative metastatic breast cancer.

One expert explained how care team aspects such as open dialogue, support and validation can help to inform patients with MPN about psychosocial needs that tend to be unmet.

Sometimes, it is better to keep things to yourself when it comes to cancer.

The Food and Drug Administration approved Keytruda plus chemotherapy for patients with locally advanced unresectable or metastatic biliary tract cancer.

After experiencing a relapse of acute myeloid leukemia, I thought about giving up, but then remembered my guiding principles.

The FDA will review SLS009 for the treatment of peripheral T-cell lymphoma, a rare and aggressive type of blood cancer.

In honor of Liver Cancer Awareness Month, CURE® highlighted some of the most impactful liver cancer developments from 2023.

An expert explained how next-generation sequencing can help patients with metastatic breast cancer understand their disease and available treatment options.

I found comfort and peace on social media from different cancer communities.

Among patients with chondrosarcomas, the most common primary bone tumor in adults, the presence of a TP53 gene mutation has been found to be associated with worse overall survival and metastasis-free survival.

Autoimmune diseases in patients with CLL are separate from CLL, which calls for different treatments.

A phase 2 study evaluated meaningful activity from lifileucel for patients with advanced mucosal melanoma who experienced disease progression on immune checkpoint inhibitors.

Patients with metastatic or recurrent head and neck squamous cell carcinoma had durable antitumor activity, according to findings from a phase 2 trial.

Sexual activity and vaginal dilation could make follow-up examinations more “tolerable” and “pain free” for survivors of cervical cancer after radiotherapy.